Keynote Address by Philip Lowe, Governor – An Efficient, Competitive and Safe Payments System – at the 2022 AusPayNet Annual Summit – Sydney Overview It was a momentous occasion at the 2022 AusPayNet Annual Summit in Sydney when Philip Lowe, Governor of the Reserve Bank of Australia, delivered a keynote address on the importance of…
Attention Shareholders: Kaskela Law LLC Launches Investigation into Athira Pharma Inc. (NASDAQ:ATHA) – Take Action Now! Investigation Announcement On December 12, 2022, Kaskela Law LLC made an important announcement regarding their investigation into Athira Pharma Inc. If you are a long-term investor in Athira Pharma, Inc. (“Athira” or the “Company”) (NASDAQ: ATHA), this information could…
Delivered Highest Revenue in Company History & Positive Gross Margin Introduces Management’s Strategic Objectives Initiates Fiscal 2023 Financial Guidance ARLINGTON, VA., Dec. 12, 2022 (GLOBE NEWSWIRE) — Fluence Energy, Inc. (Nasdaq: FLNC) Fluence Energy, Inc. Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results Fluence Energy, Inc. has recently announced its financial results for…
Humorous and Quirky Take on Securities Class Action Deadlines A Friendly Reminder from Your Favorite Investor Rights Law Firm Greetings, fellow investors! Are you a proud owner of SolarEdge Technologies, Inc. (NASDAQ: SEDG) securities? If so, buckle up because we have some important news for you. The esteemed Rosen Law Firm, known for its global…
ALX Oncology Announces Initial Data from ASPEN-05 Study of Evorpacept in Combination with Azacitidine and Venetoclax Antileukemic Activity Demonstrated ALX Oncology recently announced the initial data from the ASPEN-05 study, showcasing promising antileukemic activity in patients with both relapsed/refractory and newly diagnosed Acute Myeloid Leukemia (AML). No Observations of Cytopenias or Maximum Tolerated Dose The…
Keros Therapeutics Presents Clinical Data from its KER-050 and KER-… Keros Therapeutics Hosts Conference Call and Webcast Keros Therapeutics will be hosting a conference call and webcast today, December 12, 2022, at 4:01 p.m. ET. The event will provide an opportunity for investors, analysts, and the general public to learn more about the latest clinical…
The Investigation of Chegg, Inc. by Kaskela Law LLC Introduction On December 12, 2022, Kaskela Law LLC announced that it is investigating Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG) on behalf of the Company’s long-term stockholders. The investigation stems from a recent securities fraud complaint filed against Chegg on behalf of investors who purchased…
Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group MIAMI BEACH, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) Pasithea Therapeutics Corp. (Nasdaq: KTTA) Pasithea Therapeutics Corp., a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced that it has reached a comprehensive Settlement and…
